Jagotec AG
Records under this name other than the patents Jagotec AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 9 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,877,251 | Powder Compositions for Inhalation Grace period ended · Low confidence | Grace period ended | Low confidence | |
| US 8,697,755 | Beta 2 Adrenergic Receptor Agonists Such as Terbutaline for Use in the Treatment of Nocturnal Hypoglycemia Lapsed on the fee record Ended Apr 15, 2026 · High confidence | Lapsed on the fee record | Ended Apr 15, 2026 | High confidence |
| US 8,211,405 | Method of making a dry powder formulation Term ended Term ended Jan 29, 2025 · High confidence | Term ended | Term ended Jan 29, 2025 | High confidence |
| US 9,895,327 | Aerosol Formulations Comprising Formoterol Fumarate Dihydrate Term ended Term ended Oct 8, 2024 · Medium confidence | Term ended | Term ended Oct 8, 2024 | Medium confidence |
| US 8,309,124 | Delayed Release Tablet with Defined Core Geometry Term ended Term ended Apr 23, 2024 · High confidence | Term ended | Term ended Apr 23, 2024 | High confidence |
| US 8,394,407 | Delayed Release Tablet with Defined Core Geometry Term ended Ended no later than Apr 23, 2024 · Medium confidence | Term ended | Ended no later than Apr 23, 2024 | Medium confidence |
| US 9,040,085 | Delayed Release Tablet with Defined Core Geometry Term ended Ended no later than Apr 23, 2024 · Medium confidence | Term ended | Ended no later than Apr 23, 2024 | Medium confidence |
| US 9,186,332 | Delayed Release Tablet with Defined Core Geometry Term ended Term ended Apr 23, 2024 · Medium confidence | Term ended | Term ended Apr 23, 2024 | Medium confidence |
| US 9,884,021 | Delayed Release Tablet with Defined Core Geometry Term ended Ended no later than Apr 23, 2024 · Medium confidence | Term ended | Ended no later than Apr 23, 2024 | Medium confidence |
| US 8,246,935 | Dry powder formulations Term ended Term ended Apr 11, 2024 · From the USPTO record | Term ended | Term ended Apr 11, 2024 | From the USPTO record |